These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Ikeda S; Nakazato M; Ando Y; Sobue G Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682 [TBL] [Abstract][Full Text] [Related]
7. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan. Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231 [TBL] [Abstract][Full Text] [Related]
9. Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report. Oide T; Arima K; Yamazaki M; Hanyu N; Ikeda S Amyloid; 2004 Sep; 11(3):191-9. PubMed ID: 15523922 [TBL] [Abstract][Full Text] [Related]
10. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367 [TBL] [Abstract][Full Text] [Related]
11. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899 [TBL] [Abstract][Full Text] [Related]
12. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning? Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395 [TBL] [Abstract][Full Text] [Related]
13. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis. Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620 [TBL] [Abstract][Full Text] [Related]
14. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation. Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035 [TBL] [Abstract][Full Text] [Related]
15. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history. Rudolph T; Kurz MW; Farbu E Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975 [TBL] [Abstract][Full Text] [Related]
16. Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation. Liu J; Lan J; Zhao P; Zheng F; Song J; Zhang P; Sun X Int J Clin Exp Pathol; 2014; 7(11):7795-800. PubMed ID: 25550818 [TBL] [Abstract][Full Text] [Related]